Patrys PATDX3 antibody drug conjugate significantly increases survival in animal model
Patrys AGM – 5th Nov 2021
Patrys demonstrates potential for deoxmabs in antibody drug conjugates (ADCs)
Patrys FY21 Annual Report
QUARTERLY ACTIVITIES REPORT & 4C
PAT-DX1 Significantly Improves Survival in Animal Model of Pancreatic Cancer
New data shows PAT-DX3 able to cross the blood brain barrier
New Data | PAT-DX1
Previous
1
2
3
4
